The AstraZeneca Oxford COVID-19 vaccine (ChAdOx1 nCoV-19 and also known as AZD1222) has been shown to work as planned. A team at Bristol University has used recently developed techniques to further validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford team. This novel analysis… Read More
Almost seven in 10 Americans would be interested in receiving a COVID-19 vaccine, a study finds. But researchers say there are concerning gaps in interest, particularly among Black Americans, who suffer disproportionately from the virus. Researchers from The Ohio State University surveyed more than 2,000 Americans, asking them about their… Read More
Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could treat patients with multiple common cancers, a new clinical trial shows. It is the first trial to use the pioneering genetically targeted drug olaparib – already licensed for ovarian, breast and prostate cancer – together… Read More
AnteoTech has developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests. These can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes. The tests use AnteoTech’s patented AnteoBind activated europium technology and provide significantly higher sensitivity than that offered by currently available COVID-19… Read More
Bold Therapeutics has released data on the novel antiviral BOLD-100. In a series of experiments conducted by Dr Stephen Barr, Associate Professor in the Department of Microbiology and Immunology at Western University, BOLD-100 and remdesivir were tested head-to-head in a cytopathic effect assay against a live Wuhan strain… Read More
17 August 2020 Image: Cytonn Photography Sanofi has agreed to buy Principia Biopharma, a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases for $3.7 billion. “This acquisition advances our ongoing R&D transformation to accelerate development of the most promising medicines that will address significant patient needs,”… Read More
14 August 2020 Image: Morgan Housel Scientists at EPFL’s Brain Mind Institute have identified an enzyme that can play a central role in developing a new route of treatment for Huntington’s Disease. Huntington’s disease is a progressive and aggressively debilitating brain disorder that causes uncontrolled movements, psychological problems,… Read More
George Washington University researchers analysed five biomarkers present in the blood of hundreds of COVID-19 patients, finding elevated levels associated with higher odds of clinical deterioration and death. “When we first started treating COVID-19 patients, we watched them get better or get worse, but we didn’t know why,”… Read More
13 August 2020 Image: Edward Cisneros A non-hormonal therapy to treat hot flashes and other symptoms associated with menopause was found to be effective in a recent clinical trial. This is according to a published study by a team of researchers including faculty from the University of Colorado… Read More
